Dan Rizzo talks with Pharmaceutical Executive about biopharma product launch strategies. With connected systems and data, biopharmas can convey scientific innovation and create better HCP engagement. Learn more: https://lnkd.in/eC4ba24a

Thank you for all the great conversations at #SCOPESummit 2025! A key takeaway was the critical need for improved site collaboration.

Providing a simplified and standardized tech experience will help sites better serve patients and enhance collaboration with sponsors and CROs.

Hear how Bayer and Skylight Health Research, Inc simplify trial collaboration to bring treatments to patients faster in this video: https://lnkd.in/eh5sXRCR
#ClinicalTrials #ClinicalResearch #SCOPE2025

Veeva’s #AI Partner Program is expanding and now has more than 25 AI partners supporting 30 use cases across Commercial, R&D and Quality. Veeva’s AI Partner Program enables customer success with GenAI and seamlessly integrates with Veeva applications. Learn more and find current AI partners: https://lnkd.in/eQzKRicZ
#lifesciences #pharmaceuticals

Specialty drugs are projected to make up 65% of global pharmaceutical spending by 2025. As the stakeholder landscape expands and patient journeys become more complex, #biopharma companies must evolve their customer engagement strategies and shift from account-based selling to strategic Key Account Management. Explore this infographic to find out if you are ready for increased growth, retention, and collaboration: https://lnkd.in/gvb2_-Kq
#KAM #CRM #digitalengagement

Unifying safety systems and prioritizing clean and accurate data are top priorities for pharmacovigilance leaders in 2025. Michael Kruczek shares more about how companies like Inhibrx Biosciences, Inc. are building strong data foundations in Applied Clinical Trials Magazine: https://lnkd.in/eyJEy9G4
#pharmacovigilance #safety #pharmaceuticals